Commonwealth Equity Services’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-8,055
| Closed | -$514K | – | 4348 |
|
2025
Q1 | $514K | Buy |
8,055
+1,698
| +27% | +$108K | ﹤0.01% | 2999 |
|
2024
Q4 | $773K | Buy |
6,357
+1,151
| +22% | +$140K | ﹤0.01% | 2607 |
|
2024
Q3 | $650K | Sell |
5,206
-82
| -2% | -$10.2K | ﹤0.01% | 2685 |
|
2024
Q2 | $836K | Buy |
5,288
+45
| +0.9% | +$7.11K | ﹤0.01% | 2417 |
|
2024
Q1 | $679K | Buy |
5,243
+418
| +9% | +$54.1K | ﹤0.01% | 2554 |
|
2023
Q4 | $465K | Buy |
4,825
+415
| +9% | +$40K | ﹤0.01% | 2780 |
|
2023
Q3 | $535K | Sell |
4,410
-16
| -0.4% | -$1.94K | ﹤0.01% | 2539 |
|
2023
Q2 | $507K | Sell |
4,426
-410
| -8% | -$47K | ﹤0.01% | 2615 |
|
2023
Q1 | $666 | Sell |
4,836
-25
| -0.5% | -$3 | ﹤0.01% | 2315 |
|
2022
Q4 | $629K | Buy |
4,861
+248
| +5% | +$32.1K | ﹤0.01% | 2288 |
|
2022
Q3 | $509K | Buy |
4,613
+7
| +0.2% | +$772 | ﹤0.01% | 2391 |
|
2022
Q2 | $345K | Sell |
4,606
-3
| -0.1% | -$225 | ﹤0.01% | 2713 |
|
2022
Q1 | $360K | Sell |
4,609
-53
| -1% | -$4.14K | ﹤0.01% | 2804 |
|
2021
Q4 | $419K | Sell |
4,662
-101
| -2% | -$9.08K | ﹤0.01% | 2681 |
|
2021
Q3 | $440K | Buy |
4,763
+392
| +9% | +$36.2K | ﹤0.01% | 2572 |
|
2021
Q2 | $339K | Sell |
4,371
-200
| -4% | -$15.5K | ﹤0.01% | 2792 |
|
2021
Q1 | $340K | Sell |
4,571
-4,184
| -48% | -$311K | ﹤0.01% | 2661 |
|
2020
Q4 | $1.49M | Sell |
8,755
-251
| -3% | -$42.8K | ﹤0.01% | 1400 |
|
2020
Q3 | $1.26M | Buy |
9,006
+491
| +6% | +$68.9K | ﹤0.01% | 1357 |
|
2020
Q2 | $1.37M | Buy |
8,515
+391
| +5% | +$62.7K | 0.01% | 1239 |
|
2020
Q1 | $794K | Sell |
8,124
-3,096
| -28% | -$303K | ﹤0.01% | 1391 |
|
2019
Q4 | $1.45M | Buy |
11,220
+269
| +2% | +$34.7K | 0.01% | 1211 |
|
2019
Q3 | $824K | Buy |
10,951
+1,497
| +16% | +$113K | ﹤0.01% | 1478 |
|
2019
Q2 | $1.44M | Buy |
9,454
+290
| +3% | +$44K | 0.01% | 1134 |
|
2019
Q1 | $1.09M | Buy |
9,164
+158
| +2% | +$18.8K | 0.01% | 1256 |
|
2018
Q4 | $982K | Sell |
9,006
-217
| -2% | -$23.7K | 0.01% | 1212 |
|
2018
Q3 | $1.49M | Buy |
9,223
+234
| +3% | +$37.8K | 0.01% | 1082 |
|
2018
Q2 | $1.19M | Buy |
8,989
+892
| +11% | +$118K | 0.01% | 1189 |
|
2018
Q1 | $599K | Sell |
8,097
-994
| -11% | -$73.5K | ﹤0.01% | 1590 |
|
2017
Q4 | $506K | Buy |
9,091
+1,377
| +18% | +$76.6K | ﹤0.01% | 1693 |
|
2017
Q3 | $350K | Buy |
7,714
+650
| +9% | +$29.5K | ﹤0.01% | 1858 |
|
2017
Q2 | $238K | Buy |
+7,064
| New | +$238K | ﹤0.01% | 2091 |
|
2016
Q3 | – | Sell |
-15,828
| Closed | -$302K | – | 2302 |
|
2016
Q2 | $302K | Buy |
+15,828
| New | +$302K | ﹤0.01% | 1654 |
|
2016
Q1 | – | Sell |
-5,430
| Closed | -$209K | – | 2261 |
|
2015
Q4 | $209K | Buy |
+5,430
| New | +$209K | ﹤0.01% | 1846 |
|
2014
Q3 | – | Sell |
-10,428
| Closed | -$311K | – | 2136 |
|
2014
Q2 | $311K | Buy |
10,428
+425
| +4% | +$12.7K | ﹤0.01% | 1521 |
|
2014
Q1 | $240K | Buy |
+10,003
| New | +$240K | ﹤0.01% | 1630 |
|